Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Raw Materials (2019 - 2025)

INVO Fertility (IVF) has disclosed Raw Materials for 7 consecutive years, with $53614.0 as the latest value for Q3 2025.

  • On a quarterly basis, Raw Materials changed 0.14% to $53614.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $53614.0, a 0.14% change, with the full-year FY2024 number at $53537.0, changed 0.11% from a year prior.
  • Raw Materials was $53614.0 for Q3 2025 at INVO Fertility, up from $51501.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $77909.0 in Q1 2022 to a low of $51501.0 in Q2 2025.
  • A 5-year average of $61552.7 and a median of $62440.0 in 2023 define the central range for Raw Materials.
  • Peak YoY movement for Raw Materials: tumbled 39.09% in 2021, then grew 14.68% in 2022.
  • INVO Fertility's Raw Materials stood at $67605.0 in 2021, then grew by 1.65% to $68723.0 in 2022, then decreased by 22.18% to $53479.0 in 2023, then increased by 0.11% to $53537.0 in 2024, then grew by 0.14% to $53614.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Raw Materials are $53614.0 (Q3 2025), $51501.0 (Q2 2025), and $52660.0 (Q1 2025).